Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma

被引:23
作者
Poncelet, Alain J. [1 ]
Cornet, Julien [1 ]
Coulon, Corinne [1 ]
Collard, Philippe [3 ]
Noirhomme, Philippe [1 ]
Weynand, Birgit [2 ]
机构
[1] Univ Catholique Louvain, St Luc Hosp, Cardiovasc & Thorac Surg Unit, Dept Cardiovasc & Thorac Surg, B-1200 Brussels, Belgium
[2] Univ Catholique Louvain, St Luc Hosp, Dept Pathol, Brussels, Belgium
[3] Univ Catholique Louvain, St Luc Hosp, Dept Pulm Med, Brussels, Belgium
关键词
lung cancer; statistics; survival analysis;
D O I
10.1016/j.ejcts.2008.01.060
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective: In recent studies focusing on the prognostic significance of histologic features of NSCLC tumors, vessel invasion was correlated to survival across all surgical stages. We similarly analyzed whether intra-tumoral permeation could affect survival in subgroups of stage I and 11 NSCLC. Methods: A retrospective single institution analysis of a prospectively computed database. Specimens were analyzed for intra-tumoral vascular, lymphatic and nervous permeation. Overall mortality was determined and for each stage, a Cox regression analysis of selected variables was performed. Detailed histologic information was available in all patients. Follow-up was 100% complete (median = 69 months). Results: From 1989 to 2004, out of 346 patients with stage I and 11 NSCLC, 253 patients with p stage 1 (75.7%) and 81 patients with p stage 11 (24.3%) underwent surgery with complete resection, for a completeness resection rate of 97% (334/346). We performed 70 pneumonectomies, 255 lobectomies and 9 lesser resections (respectively, 21%, 76.3% and 2.7%). In-hospital mortality was 2.1%. The incidence of intra-tumoral permeation was 14.4% (48/334). Permeation correlated both with T status (p = 0.04), grade of differentiation (p = 0.03) and stage (p = 0.02). Median survival and overall 5-year survival for patients with and without permeation were 42.3 months (95% CI [20-64.6]) and 72.1 months (95% CI [56.9-87.2]), respectively; and 44% and 54%, respectively to = NS). However, intra-tumoral permeation was not a significant predictor for overall death (HR = 1.1 [95% CI = 0.74-1.66). Conclusion: In this large institutional study of early stage NSCLC, the presence of intra-tumoral permeation was correlated both to T, grade of differentiation, as well as to stage. However, in contrast to recent reports, we did not find that intra-tumoral permeation adversely affects tong-term survival. (C) 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:799 / 804
页数:6
相关论文
共 21 条
[1]
Where is the boundary between N1 and N2 stations in lung cancer? [J].
Asamura, H ;
Suzuki, K ;
Kondo, H ;
Tsuchiya, R .
ANNALS OF THORACIC SURGERY, 2000, 70 (06) :1839-1845
[2]
Brechot JM, 1996, CANCER-AM CANCER SOC, V78, P2111, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2111::AID-CNCR11>3.0.CO
[3]
2-1
[4]
Analysis of pathological risk factors for lymph node metastasis of submucosal invasive colon cancer [J].
Egashira, Y ;
Yoshida, T ;
Hirata, I ;
Hamamoto, N ;
Akutagawa, H ;
Takeshita, A ;
Noda, N ;
Kurisu, Y ;
Shibayama, Y .
MODERN PATHOLOGY, 2004, 17 (05) :503-511
[5]
Histological characteristics of tumor in vessels and lymph nodes are significant predictors of progression of invasive ductal carcinoma of the breast: A prospective study [J].
Hasebe, T ;
Sasaki, S ;
Imoto, S ;
Ochiai, A .
HUMAN PATHOLOGY, 2004, 35 (03) :298-308
[6]
HERMANEK P, 1994, PATHOL RES PRACT, V190, P115
[7]
Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung [J].
Khan, OA ;
Fitzgerald, JJ ;
Field, ML ;
Soomro, I ;
Beggs, FD ;
Morgan, WE ;
Duffy, JP .
ANNALS OF THORACIC SURGERY, 2004, 77 (04) :1173-1178
[8]
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer [J].
Le Chevalier, T ;
Arriagada, R ;
Le Péchoux, C ;
Grunenwald, D ;
Dunant, A ;
Pignon, JP ;
Tarayre, M ;
Abratt, R ;
Arriagada, R ;
Bergman, B ;
Gralla, R ;
Grunenwald, D ;
Le Chevalier, T ;
Orlowski, T ;
Papadakis, E ;
Pinel, MIS ;
Araujo, C ;
Della Torre, H ;
de Solchaga, MM ;
Abdi, E ;
Blum, R ;
Ball, D ;
Basser, R ;
De Boer, R ;
Bishop, J ;
Brigham, B ;
Davis, S ;
Fox, D ;
Richardson, G ;
Wyld, D ;
Pirker, R ;
Humblet, Y ;
Delaunois, L ;
Van Meerbeeck, JP ;
Germonpre, P ;
Vansteenkiste, J ;
Nackaerts, K ;
Pinel, MIS ;
Vauthier, G ;
Younes, RN ;
Arriagada, R ;
Baeza, R ;
Carvajal, P ;
Kleinman, S ;
Orlandi, L ;
Castro, C ;
Godoy, J ;
Kosatova, K ;
Gaafar, R ;
Azarian, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04) :351-360
[9]
Magnano M, 1999, J EXP CLIN CANC RES, V18, P79
[10]
SURVIVAL AFTER RESECTION OF STAGE-II NON-SMALL-CELL LUNG-CANCER [J].
MARTINI, N ;
BURT, ME ;
BAINS, MS ;
TODD, TRJ ;
MCCORMACK, PM ;
RUSCH, VW ;
GINSBERG, RJ ;
CHAMBERS, JS .
ANNALS OF THORACIC SURGERY, 1992, 54 (03) :460-466